Skip to main content
Granules India Limited (NSE:GRANULES)
India flag India · Delayed Price · Currency is INR
704.55
-0.60 (-0.09%)
Apr 29, 2026, 3:30 PM IST

Granules India Revenue

Granules India had revenue of 13.88B INR in the quarter ending December 31, 2025, with 22.00% growth. This brings the company's revenue in the last twelve months to 50.92B, up 14.18% year-over-year. In the fiscal year ending March 31, 2025, Granules India had annual revenue of 44.82B, down -0.55%.

Revenue (ttm)
50.92B
Revenue Growth
+14.18%
P/S Ratio
3.43
Revenue / Employee
12.52M
Employees
4,066
Market Cap
174.85B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 202544.82B-247.59M-0.55%
Mar 31, 202445.06B-55.50M-0.12%
Mar 31, 202345.12B7.47B19.84%
Mar 31, 202237.65B5.27B16.29%
Mar 31, 202132.38B6.39B24.59%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Eris Lifesciences 30.65B
Cohance Lifesciences 10.79B
NATCO Pharma 45.63B
Alembic Pharmaceuticals 72.67B
Piramal Pharma 88.71B
Wockhardt 31.74B
Alivus Life Sciences 25.12B
Gland Pharma 61.13B
Revenue Rankings

Granules India News

More News